These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3065788)
1. [The optimization of bioactive lead structure I. Test of the system]. Mager PP Pharm Unserer Zeit; 1988 Jul; 17(4):106-26. PubMed ID: 3065788 [No Abstract] [Full Text] [Related]
2. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence? Griffen EJ; Dossetter AG; Leach AG; Montague S Drug Discov Today; 2018 Jul; 23(7):1373-1384. PubMed ID: 29577971 [TBL] [Abstract][Full Text] [Related]
3. [The principle of pro-drug in drug design (author's transl)]. Guo ZR Yao Xue Xue Bao; 1979; 14(9):566-76. PubMed ID: 532661 [No Abstract] [Full Text] [Related]
4. Role of drug metabolism in drug research and development: view of a medicinal chemist. Clarke FH J Pharm Sci; 1972 Oct; 61(10):1678-82. PubMed ID: 5072431 [No Abstract] [Full Text] [Related]
7. Air-dictated bottom spray process: impact of fluid dynamics on granule growth and morphology. Liew CV; Er DZ; Heng PW Drug Dev Ind Pharm; 2009 Jul; 35(7):866-76. PubMed ID: 19466895 [TBL] [Abstract][Full Text] [Related]
8. Asymmetric synthesis of active pharmaceutical ingredients. Farina V; Reeves JT; Senanayake CH; Song JJ Chem Rev; 2006 Jul; 106(7):2734-93. PubMed ID: 16836298 [No Abstract] [Full Text] [Related]
9. [Concepts of synthesis in drug research]. Mager PP Pharm Unserer Zeit; 1984 Jan; 13(1):1-12. PubMed ID: 6701175 [No Abstract] [Full Text] [Related]
11. Selective optimization of side activities: another way for drug discovery. Wermuth CG J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318 [No Abstract] [Full Text] [Related]